4//SEC Filing
Zinda Michael 4
Accession 0001209191-22-004046
CIK 0001808158other
Filed
Jan 19, 7:00 PM ET
Accepted
Jan 20, 4:42 PM ET
Size
5.6 KB
Accession
0001209191-22-004046
Insider Transaction Report
Form 4
Zinda Michael
EVP, CHIEF SCIENTIFIC OFFICER
Transactions
- Exercise/Conversion
Employee Stock Option (right to buy)
2022-01-18+115,000→ 115,000 totalExercise: $15.63Exp: 2032-01-17→ Common Shares (115,000 underlying)
Footnotes (1)
- [F1]Twenty-five percent (25%) of the shares subject to the option shall vest on January 18, 2023, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to Reporting Person continuing to provide service through each such date.
Documents
Issuer
Repare Therapeutics Inc.
CIK 0001808158
Entity typeother
Related Parties
1- filerCIK 0001815366
Filing Metadata
- Form type
- 4
- Filed
- Jan 19, 7:00 PM ET
- Accepted
- Jan 20, 4:42 PM ET
- Size
- 5.6 KB